IHS Life Sciences Risk Sharing Workshop presentation shortIHS
Presentation given by Milena Izmirlieva , Senior Manager, Research Life Sciences, IHS at the 2015 CBI Reimbursement and Contracting conference in Philadelphia
Collaborating for Sustainable Water Management in the Oil and Gas IndustryIHS
Sarah Fletcher, Senior Research Analyst at IHS, presents at the 23rd Annual World Water Week, September 2-6, 2013 in Stockholm Sweden. World Water Week is the preeminent water conference for academic research on water. Sarah’s presentation, “Collaborating for Sustainable Water Management in the Oil and Gas Industry,” is part of an entire workshop on linking science, practice and policy under increasing complexity and uncertainty. www.ihs.com
IHS Goldfire is software that helps engineers, scientists and researchers to develop, maintain and produce breakthrough products.
Powered by world-class semantic search technology, IHS Goldfire transforms internal
and external information into actionable innovation intelligence.
IHS Goldfire helps organizations identify new markets, develop new products, mitigate risk and drive efficiencies.
IHS Life Sciences Risk Sharing Workshop presentation shortIHS
Presentation given by Milena Izmirlieva , Senior Manager, Research Life Sciences, IHS at the 2015 CBI Reimbursement and Contracting conference in Philadelphia
Collaborating for Sustainable Water Management in the Oil and Gas IndustryIHS
Sarah Fletcher, Senior Research Analyst at IHS, presents at the 23rd Annual World Water Week, September 2-6, 2013 in Stockholm Sweden. World Water Week is the preeminent water conference for academic research on water. Sarah’s presentation, “Collaborating for Sustainable Water Management in the Oil and Gas Industry,” is part of an entire workshop on linking science, practice and policy under increasing complexity and uncertainty. www.ihs.com
IHS Goldfire is software that helps engineers, scientists and researchers to develop, maintain and produce breakthrough products.
Powered by world-class semantic search technology, IHS Goldfire transforms internal
and external information into actionable innovation intelligence.
IHS Goldfire helps organizations identify new markets, develop new products, mitigate risk and drive efficiencies.
IHS Analysis - Beirut Bombing - Hizbullah Targeted by MilitantsIHS
On 9 July, as many as 37 people were wounded in a vehicle-borne improvised explosive attack in Bir al-Abed, a Hizbullah stronghold in the south of Lebanon’s capital Beirut. The attack followed a series of threats in recent days by Syria-based militant Islamist groups to target Hizbullah areas in Lebanon.
Three states in southern Somalia are keen to become an autonomous region known as Jubbaland. IHS examines why the central Somali government opposes these plans, despite initially backing the idea.
Naval participation in counter-piracy operations around the Horn of Africa has been a success, but does this mean a long-term commitment from governments, or will a change in priorities mean that they leave before the situation is solved? IHS Jane's Defence Weekly Naval Editor Dr Lee Willett examines the issues.
With the Obama Administration’s pivot to the Asia-Pacific region, IHS attended the Pacific Operational S&T Conference and Exhibition on 5-8 March in Honolulu, Hawaii, for an update on US Pacific Command’s (PACOM) priorities and challenges.
This presentation provides selected IHS analysis of the event, its themes, outcomes and implications.
What You Need To Know About The Year Ahead In Africa And The Middle East - IH...IHS
International affairs always hold the potential to surprise, but despite the myriad permutations that surround this volatile region there are firm, fixed events – elections, military exercises, international conferences – and ongoing strategic trends and pressures that provide a static framework around which events are likely to unfold.
This IHS white paper sketches out the themes, issues and potential flashpoints that could come to define 2013 in this part of the world.
IHS Analysis - Sub-Saharan Africa Defence Budget Trends - December 2012IHS
The endurance of the global financial crisis has meant the economies of the Europe and North America have continued to struggle with slow export growth and significant fiscal challenges. As traditional Western defence markets fail to recover, new opportunities are being sought in territories previously viewed as unviable. Senior Analysts from IHS Jane’s Defence Budgets examine one of these potential markets – Sub-Saharan Africa – to determine the significance of the market.
North Korea has successfully launched its Unha-3 SLV and put a satellite into orbit, US officials have confirmed. Seoul and Washington condemned the launch, which is widely seen as a part of North Korea’s ICBM programme, while China expressed ‘regret’. IHS examines the impact and regional implications.
Drug prices and_market_access_across_europe_webcast_european_turmoil_2012IHS
The slides from the IHS Healthcare and Pharma webcast held on 15 November, 2012 titled European Turmoil 2012: A Review of Drug Prices and Market Access Across Europe
IHS has determined that Iran's new launch tower at Semnan will be able to facilitate the launch of a rocket even larger than those reportedly under development.
The Role of Technology For Patient Outcomes in East Africa — Slides from East...IHS
These slides were presented by Farah Ramadan at the East Africa Healthcare Investment Summit 2012 in Kampala, Uganda on 19th April 2012.
The presentation was part of a panel discussion with government and industry representatives, examining strategies for sustained growth and profitability in the healthcare arena in East Africa.
This presentation focused specifically on the role of technology as an enabling force for better patient outcomes in East Africa.
IHS Analysis - Beirut Bombing - Hizbullah Targeted by MilitantsIHS
On 9 July, as many as 37 people were wounded in a vehicle-borne improvised explosive attack in Bir al-Abed, a Hizbullah stronghold in the south of Lebanon’s capital Beirut. The attack followed a series of threats in recent days by Syria-based militant Islamist groups to target Hizbullah areas in Lebanon.
Three states in southern Somalia are keen to become an autonomous region known as Jubbaland. IHS examines why the central Somali government opposes these plans, despite initially backing the idea.
Naval participation in counter-piracy operations around the Horn of Africa has been a success, but does this mean a long-term commitment from governments, or will a change in priorities mean that they leave before the situation is solved? IHS Jane's Defence Weekly Naval Editor Dr Lee Willett examines the issues.
With the Obama Administration’s pivot to the Asia-Pacific region, IHS attended the Pacific Operational S&T Conference and Exhibition on 5-8 March in Honolulu, Hawaii, for an update on US Pacific Command’s (PACOM) priorities and challenges.
This presentation provides selected IHS analysis of the event, its themes, outcomes and implications.
What You Need To Know About The Year Ahead In Africa And The Middle East - IH...IHS
International affairs always hold the potential to surprise, but despite the myriad permutations that surround this volatile region there are firm, fixed events – elections, military exercises, international conferences – and ongoing strategic trends and pressures that provide a static framework around which events are likely to unfold.
This IHS white paper sketches out the themes, issues and potential flashpoints that could come to define 2013 in this part of the world.
IHS Analysis - Sub-Saharan Africa Defence Budget Trends - December 2012IHS
The endurance of the global financial crisis has meant the economies of the Europe and North America have continued to struggle with slow export growth and significant fiscal challenges. As traditional Western defence markets fail to recover, new opportunities are being sought in territories previously viewed as unviable. Senior Analysts from IHS Jane’s Defence Budgets examine one of these potential markets – Sub-Saharan Africa – to determine the significance of the market.
North Korea has successfully launched its Unha-3 SLV and put a satellite into orbit, US officials have confirmed. Seoul and Washington condemned the launch, which is widely seen as a part of North Korea’s ICBM programme, while China expressed ‘regret’. IHS examines the impact and regional implications.
Drug prices and_market_access_across_europe_webcast_european_turmoil_2012IHS
The slides from the IHS Healthcare and Pharma webcast held on 15 November, 2012 titled European Turmoil 2012: A Review of Drug Prices and Market Access Across Europe
IHS has determined that Iran's new launch tower at Semnan will be able to facilitate the launch of a rocket even larger than those reportedly under development.
The Role of Technology For Patient Outcomes in East Africa — Slides from East...IHS
These slides were presented by Farah Ramadan at the East Africa Healthcare Investment Summit 2012 in Kampala, Uganda on 19th April 2012.
The presentation was part of a panel discussion with government and industry representatives, examining strategies for sustained growth and profitability in the healthcare arena in East Africa.
This presentation focused specifically on the role of technology as an enabling force for better patient outcomes in East Africa.
Pharmaceutical Lifecycle Management Challenges - Slides from Pharmaceutical P...
Availability and pricing of innovative pharmaceuticals in the top 5 european pharmaceutical markets
1. Availability and Pricing of New
Pharmaceuticals in the Top 5
European Pharmaceutical Markets
Reinaud F, Ando G (IHS, London, United Kingdom)
Objectives Among the innovative medicinal products available in each of the
top-five European pharmaceutical markets, manufacturer prices of
Pharmacoeconomics and cost-effectiveness assessments are 10 drugs were compared. For each drug, the ranking of the
increasingly taken into account in pricing and/or reimbursement markets studied from the highest manufacture price (1) to the
decisions. In an attempt to measure the impact those lowest (5) is summarised in the following table.
assessments have on time to pricing and price levels of innovative
Table 3: Ranking of the top-five European pharmaceutical markets
drugs, we surveyed market availability and drug prices for a
according to manufacturer price levels
basket of 125 innovative medicinal products in the top-five
European pharmaceutical markets. Brand name Germany Italy Spain UK France
Gilenya 1 3 5 2 4
Methods Vpriv
Ozurdex
1
1
5
5
3
4
2
2
5
3
The price availability of 125 innovative medicinal products— Revolade 2 1 3 5 4
approved between July 2009 and April 2012 by the EMA—in Onbrez Breezhaler 1 5 2 3 4
France, Germany, Italy, Spain, and the United-Kingdom was Ilaris 4 5 3 1 2
analysed. Cimzia 1 3 2 4 5
Onglyza 1 2 3 5 4
Manufacturer prices of 10 innovative drugs available in each of the Mozobil 3 1 4 5 2
markets studied were then compared. In order to do so, VAT, Eporatio 2 1 3 5 4
pharmacists’ margins, and wholesalers’ margins were removed Ranking Average 1.7 3.1 3.2 3.4 3.7
from retail prices provided by sources.
Source: IHS PharmOnline International; exchange rate UK: 1 GBP = 1.25367 EUR
Results Data indicate that prices of drugs are usually the highest in
Germany (they were the highest in 6 out of the 10 case studies). It
Table 1: Market availability of drugs in the top-five European pharmaceutical markets comes as no surprise considering that most drugs for which
out of the 125 innovative drugs approved by EMA between July 2009 and April 2012 prices were compared had been approved before the AMNOG
pricing reform, and none of them belongs to the 27 drugs that
Number of drugs available out of the
125 innovative drugs approved by Percentage completed the early benefit assessment.
EMA between July 2009 and April 2012
Prices of innovative drugs tend to be the lowest in France. This
Germany 74 59% result is unexpected given the fact that French legislation specifies
UK 67 54% that prices of drugs deemed innovative (ASMR ratings from I to III)
Spain 49 39% cannot be lower than the lowest price in Germany, Italy, Spain,
France 41 33% and the UK. However, the French National Authority for Health
Italy 40 32%
(HAS) is increasingly stringent when granting ASMR ratings, as
Source: IHS PharmOnline International
demonstrated by the annual activity reports: 18 ASMR from I to III
were granted in 2009. This figure dropped to 13 in 2010 and only
A limited number of the innovative drugs (17) included in the
1 in 2011.
sample analysed are available in each of the top-five European
pharmaceutical markets, although most of them were approved
by EMA at least year years ago. Conclusions
Table 2: Listing of the innovative medicinal products approved by EMA between As summarised in the following chart, Germany is where the most
July 2009 and April 2012 available in each of the top-five European pharmaceutical markets
innovative drugs are available and prices are the highest.
Brand name Marketing approval date Conversely, France has fewer innovative drugs available—due to
longer pricing procedures—and the lowest prices—due to the
Gilenya 17/03/2011
increasingly stringent assessment of drug innovation provided by
Jevtana 17/03/2011
the HAS. In Italy, Spain, and the UK, price levels differ on a case-
Vpriv 26/08/2010
by-case basis. In the UK, more drugs are available, while in Italy,
Ozurdex 27/07/2010
prices of orphan drugs tend to be higher.
Votrient 14/06/2010
Nivestim 08/06/2010
Menveo 15/03/2010
Revolade 11/03/2010
Prevenar 13 09/12/2009
Onbrez Breezhaler 30/11/2009
Multaq 26/11/2009
Eporatio 29/10/2009
Ilaris 23/10/2009
Resolor 15/10/2009
Cimzia 01/10/2009
Onglyza 01/10/2009
Mozobil 31/07/2009
Source: European Medicines Agency (EMA) and IHS PharmOnline International
FOR MORE INFORMATION ABOUT IHS GLOBAL INSIGHT HEALTHCARE & PHARMACEUTICAL SERVICES
www.ihs.com/healthcare and www.ihs.com/healthcareblog
Please email: gustav.ando@ihs.com for any questions related to this poster